Send to

Choose Destination
See comment in PubMed Commons below
Gynecol Oncol. 1994 Nov;55(2):304-7.

Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen.

Author information

Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota 55905.


Skene's (periurethral) gland carcinoma is a rare neoplasm accounting for less than 0.003% of all genital tract malignancies in females. Generally, adenocarcinomas of the female urethra are assumed to arise from the periurethral glands, the female homologue of the prostate. A case of Skene's gland adenocarcinoma without mucosal urethral involvement is presented. The histologic features of this tumor closely resembled those of prostatic adenocarcinoma. In contrast, clear cell and columnar/mucinous variants of female urethral adenocarcinomas have been described previously. Perhaps this signifies different biologic processes in the development of Skene's/periurethral and urethral adenocarcinomas in females. Additionally, we performed immunohistochemical staining that was reactive for prostate-specific antigen (PSA). Preoperatively, the serum level of PSA was increased and promptly decreased after surgical excision of the lesion. Therefore, preoperative and postoperative monitoring of serum PSA titers in patients with adenocarcinomas of the female urethra or periurethral glands (or both) should be considered.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center